Literature DB >> 3264803

Immunostaining for alpha 1-antichymotrypsin and alpha 1-antitrypsin in gliomas.

H K Ng1, S T Lo.   

Abstract

Antisera to alpha 1-antichymotrypsin, alpha 1-antitrypsin and lysozyme were reacted with 20 cases of glioblastoma multiforme, seven anaplastic astrocytomas, eight astrocytomas, six oligodendrogliomas, four ependymomas and the cerebral cortex from six normal autopsy brains. In addition, two pleomorphic xantho-astrocytomas and two heavily lipidized malignant gliomas were similarly examined. All astrocytic lesions were confirmed with anti-GFAP antisera. Thirty astrocytic tumours (77%), four oligodendrogliomas (67%) and three ependymomas (75%) reacted positively with anti-alpha 1-antichymotrypsin; 25 astrocytic tumours (64%), three oligodendrogliomas (50%) and three ependymomas (75%) showed positive staining for alpha 1-antitrypsin. The pattern of staining with either of these two markers did not correlate with tumour grading. None of the gliomas examined stained positively with anti-lysozyme. Non-neoplastic glial elements did not react with any of the three antisera. The results of this study suggest that staining for alpha 1-antichymotrypsin and alpha 1-antitrypsin is of little value in the differential diagnosis of neuroepithelial or mesenchymal lesions in the brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264803     DOI: 10.1111/j.1365-2559.1988.tb02005.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm. A study of 3 cases.

Authors:  J J Kepes; L J Rubinstein; L Ansbacher; D J Schreiber
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.

Authors:  J M Rozemuller; J J Abbink; A M Kamp; F C Stam; C E Hack; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Mitotic activity of multinucleated giant cells with glial fibrillary acidic protein immunoreactivity in glioblastomas: an immunohistochemical double labeling study.

Authors:  Hiroaki Takeuchi; Kazufumi Sato; Kazunori Ido; Toshihiko Kubota
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

4.  Gliosarcoma: an immunohistochemical study.

Authors:  J W Grant; P V Steart; A Aguzzi; D B Jones; P J Gallagher
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Cytoplasmic inclusions of astrocytic elements of glial tumors: special reference to round granulated body and eosinophilic hyaline droplets.

Authors:  T Hitotsumatsu; T Iwaki; M Fukui; J Tateishi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients.

Authors:  Dingyuan Luo; Wei Chen; Yun Tian; Junliang Li; Xinke Xu; Cheng Chen; Fangcheng Li
Journal:  Onco Targets Ther       Date:  2017-04-18       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.